Skip to main content
. 2012 Jul 11;7(7):e39222. doi: 10.1371/journal.pone.0039222

Table 4. Adverse events (n) reported during the observation, classified by CTCAE grade.

Adverse event (>1)* Grade1 Grade2 Grade3 Grade4 Grade5
ALT Elevation 21 18 9 1§
AST Elevation 31 2 6 1§
Triglyceride elevation 64 64 28
Total Cholesterol elevation 157 32 1
CK Elevation 2 1
Non-Hodgkin’s Lymphoma 1 5
Liver Cirrhosis 26 22 18 15 3
Acute Myocardial Infarction 2 1
Pulmonary Tuberculosis 1
Hepatocarcinoma 2
Acute psychosis 1 1
Fatigue/Malaise 2
Gastrointestinal Intolerance 2 1 1
Anxiety 1 1
Headache 2
Weight Loss 2
Flu-like Symptoms 2 1
Myalgia 2 1
§

Acute hepatitis HBV,

*

Plus one case of: renal cancer, grade 3 rhabdomyolysis, non-Hodgkin’s lymphoma, coronary heart disease, diabetes, Basedow’s disease, portal hypertension, arterial hypertension, urinary tract infection, fever, acute psychosis, dizziness, flushing, macular rash of skin and glans, gout, cataract, dry skin, asymptomatic hyperuricemia and LDH increase.